# Reducing Innate Inflammation in New Onset Type 1 Diabetes

> **NCT04335656** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 60 (estimated)

## Conditions studied

- Type 1 Diabetes
- type1diabetes
- Type 1 Diabetes Mellitus

## Interventions

- **DIETARY_SUPPLEMENT:** Lactiplantibacillus plantarum
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04335656
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04335656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04335656, "Reducing Innate Inflammation in New Onset Type 1 Diabetes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04335656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*